ROG 68.95 Rogers Corp $ROG Hit a 52 week high of 6
Post# of 39
Posted On: 11/04/2014 1:20:38 AM
ROG 68.95 Rogers Corp $ROG Hit a 52 week high of 69.81 Closing the day 11/03/14 at 68.95 +0.58 +0.85% With a day low of 68.08 and a total volume of 290,227.
ROG Recent Posts: http://investorshangout.com/Rogers-Corp-ROG-52545/
ROG Rogers Corp Recent Headline News
Uptrend Call Working As Rogers Stock Rises 22.9% (ROG)
Comtex SmarTrend(R) - Fri Oct 31, 9:23AM CDT
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.50. In approximately 2 weeks, Rogers has returned 22.89% as of today's recent price of $68.20.
ROG: 68.95 (+0.58)
NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
DHX: 9.81 (-0.16), CALX: 10.84 (+0.03), EGL: 43.42 (+0.22), V: 241.54 (+0.11), OCN: 22.72 (-0.84), GNC: 41.47 (-0.10), ROG: 68.95 (+0.58), DRL: 5.55 (-0.26), ACCO: 8.33 (+0.10), CEB: 73.22 (-0.48), FLTX: 36.03 (-1.11)
Peter C. Wallace Elected Chairman of Applied Industrial Technologies Board of Directors
PR Newswire - Wed Oct 29, 5:31AM CDT
The Board of Directors of Applied Industrial Technologies (NYSE: AIT) has elected Peter C. Wallace as its independent Chairman. He succeeds John F. Meier, who has served as Chairman since 2011 and who will continue to serve as a member of the Board.
ROG: 68.95 (+0.58), AIT: 48.63 (-0.18)
Rogers Corp. posts 3Q profit
Automated Insights - Tue Oct 28, 3:58PM CDT
ROGERS, Conn. (AP) _ Rogers Corp. (ROG) on Tuesday reported earnings of $20.4 million, or $1.09 per share, in its third quarter.
ROG: 68.95 (+0.58)
Rogers Corporation Reports All-Time Record Quarterly Sales for the Third Quarter of 2014
Business Wire - Tue Oct 28, 3:01PM CDT
--Earnings per diluted share of $1.09
ROG: 68.95 (+0.58)
Rogers Corporation Invites You to Join its Third Quarter 2014 Conference Call
Business Wire - Tue Oct 21, 7:27AM CDT
Rogers Corporation (NYSE: ROG) plans to release results for its 2014 third quarter after the close of trading on Tuesday, October 28, 2014. A copy of the announcement will be available on the Rogers website at www.rogerscorp.com/news.
ROG: 68.95 (+0.58)
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors
GlobeNewswire - Mon Oct 20, 6:00AM CDT
NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, announced today that they have entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group (SIX:RO) (SIX:ROG) (OTCQX:RHHBY), for the development of NLG919, NewLink's IDO pathway inhibitor. The parties also entered into a research collaboration for the discovery of next generation IDO/TDO compounds.
NLNK: 32.61 (-0.04), ROG: 68.95 (+0.58)
Rogers names Helene Simonet to its board as director
M2 - Wed Oct 15, 6:57AM CDT
Rogers Corporation (NYSE:ROG), a high-performance engineered materials solutions company, announced on Wednesday that Helene Simonet has been appointed to its board of directors, filling the vacancy left by a recently retired director.
ROG: 68.95 (+0.58), COHR: 64.84 (-0.31)
Shares of ROG Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 14, 5:06PM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 16.14% as of today's recent price of $53.40.
ROG: 68.95 (+0.58)
Rogers Corporation Appoints Helene Simonet to Its Board of Directors
Business Wire - Tue Oct 14, 3:00PM CDT
Rogers Corporation (NYSE: ROG) today announced that its Board of Directors has appointed Helene Simonet to serve as a member of the Company's Board. This addition fills a vacancy on the Board due to a recent director retirement. Ms. Simonet will be a member of the Audit Committee.
ROG: 68.95 (+0.58), COHR: 64.84 (-0.31)
Rogers Shares Down 15.4% Since SmarTrend's Sell Call (ROG)
Comtex SmarTrend(R) - Tue Oct 07, 11:08AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 15.37% as of today's recent price of $53.89.
ROG: 68.95 (+0.58)
Industry Leaders Form the RF Energy Alliance to Facilitate the Adoption of Solid-State RF Energy Technology
Business Wire - Mon Oct 06, 9:00AM CDT
Industry leaders, including E.G.O. Elektro-Geratebau GmbH, Huber+Suhner, ITW, NXP Semiconductors, Rogers Corporation and Whirlpool R&D (an affiliate company of Whirlpool Corporation), today announced the formation of the RF Energy Alliance. This consortium intends to advance today's power and heating solutions by equipping engineers and designers with a transformative, cost-effective and highly efficient heating and power source--solid-state radio frequency (RF) energy. To achieve this, the Alliance will drive the development of standards, education and promotion of solid-state RF energy.
WHR: 172.60 (+0.55), ROG: 68.95 (+0.58)
14.4% Return Seen to Date on SmarTrend Rogers Call (ROG)
Comtex SmarTrend(R) - Tue Sep 30, 9:44AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 2 months, Rogers has returned 14.43% as of today's recent price of $54.49.
ROG: 68.95 (+0.58)
Analysis of the Global High-performance (HP) Foams Market Outlook 2018 Featuring 3M, Rogers Corporation, Saint Gobain & Zotefoam
M2 - Thu Sep 25, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpv22d/analysis_of_the) has announced the addition of the "Analysis of the Global High-performance (HP) Foams Market" report to their offering. This research service identifies the major industry drivers, restraints, regional trends, and segment trends in the global HP foams market. The research covers 4 regions: North America, Europe, Asia-Pacific, and Rest of World and accounts for revenue generated from urethane, silicone, and polyvinylidene fluoride (PVDF) foams used in construction and transportation (automotive, rail, and aerospace) applications. Competitive structure and dynamics have been provided at the segment level. Unit shipment, revenue forecasts, and pricing trends are also provided for each segment. The base year is 2013, and the forecast period is from 2014 to 2018. Key Questions This Study Will Answer - Is the market growing, how long will it continue to grow, and at what rate? - What are some of the factors that have had a significant impact on the market's performance? - Who are the market leaders? How might the structure of the market change over time? - How are the existing competitors structuring themselves correctly to meet customer needs? - Are today's products meeting end-user needs? How are manufacturers marketing new products? - Which product attributes do end users find most important? How do these impact selection? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Drivers And Restraints - Total Hp Foams Market 4. Forecast And Trends - Total Hp Foams Market 5. Market Share And Competitive Analysis - Total Hp Foams Market 6. Ceo'S 360 Degree Perspectiveon The Total Hp Foams Market 7. Urethane Segment Breakdown 8. Silicone Segment Breakdown 9. PVDF Segment Breakdown 10. The Last Word 11. Appendix Companies Mentioned - 3M - Rogers Corporation - Saint Gobain - Zotefoam For more information visit http://www.researchandmarkets.com/research/zp...sis_of_the
ROG: 68.95 (+0.58)
Rogers Has Returned 11.7% Since SmarTrend Recommendation (ROG)
Comtex SmarTrend(R) - Tue Sep 23, 9:18AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 2 months, Rogers has returned 11.75% as of today's recent price of $56.20.
ROG: 68.95 (+0.58)
Seragon Pharmaceuticals Inc. Announces Closing of Its Acquisition by Genentech
GlobeNewswire - Wed Aug 27, 3:15PM CDT
Seragon Pharmaceuticals Inc., a leader in developing drugs for hormone dependent cancers, today announced the closing of its acquisition by Genentech, a member of the Roche Group, (SIX:RO) (SIX:ROG) (OTCQX:RHHBY). Deal terms included $725 million in cash up front along with $1.0 billion in contingent development milestone payments for total transaction value up to $1.725 billion. The acquisition includes Seragon's entire selective estrogen receptor degrader (SERD) program, including its most advanced compound, ARN-810, a next generation SERD that is currently being evaluated in a Phase I trial in postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) breast cancer.
ROG: 68.95 (+0.58)
Harwood Feffer LLP Announces Investigation of Intermune, Inc.
PR Newswire - Mon Aug 25, 1:17PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Intermune, Inc. ("Intermune" or the "Company"
(NASDAQ: ITMN) concerning the proposed acquisition of the Company by Roche Holding AG ("Roche" (SIX:ROG) (OTCQX:RHHBY).
ITMN: 73.89 (-0.02), ROG: 68.95 (+0.58)
What Falling Estimates & Price Mean for Rogers Corporation (ROG) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 7:43AM CDT
Rogers Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
NJ: 16.82 (+0.15), PKE: 25.40 (-0.40), ROG: 68.95 (+0.58), AVX: 14.33 (-0.11)
Rogers Corporation Reports All-Time Record Quarterly Sales for the Second Quarter of 2014
Business Wire - Tue Jul 29, 3:02PM CDT
--37.2% gross margin -- up 330 basis points relative to prior year non-GAAP measure
ROG: 68.95 (+0.58)
ROG Recent Posts: http://investorshangout.com/Rogers-Corp-ROG-52545/
ROG Rogers Corp Recent Headline News
Uptrend Call Working As Rogers Stock Rises 22.9% (ROG)
Comtex SmarTrend(R) - Fri Oct 31, 9:23AM CDT
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.50. In approximately 2 weeks, Rogers has returned 22.89% as of today's recent price of $68.20.
ROG: 68.95 (+0.58)
NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
DHX: 9.81 (-0.16), CALX: 10.84 (+0.03), EGL: 43.42 (+0.22), V: 241.54 (+0.11), OCN: 22.72 (-0.84), GNC: 41.47 (-0.10), ROG: 68.95 (+0.58), DRL: 5.55 (-0.26), ACCO: 8.33 (+0.10), CEB: 73.22 (-0.48), FLTX: 36.03 (-1.11)
Peter C. Wallace Elected Chairman of Applied Industrial Technologies Board of Directors
PR Newswire - Wed Oct 29, 5:31AM CDT
The Board of Directors of Applied Industrial Technologies (NYSE: AIT) has elected Peter C. Wallace as its independent Chairman. He succeeds John F. Meier, who has served as Chairman since 2011 and who will continue to serve as a member of the Board.
ROG: 68.95 (+0.58), AIT: 48.63 (-0.18)
Rogers Corp. posts 3Q profit
Automated Insights - Tue Oct 28, 3:58PM CDT
ROGERS, Conn. (AP) _ Rogers Corp. (ROG) on Tuesday reported earnings of $20.4 million, or $1.09 per share, in its third quarter.
ROG: 68.95 (+0.58)
Rogers Corporation Reports All-Time Record Quarterly Sales for the Third Quarter of 2014
Business Wire - Tue Oct 28, 3:01PM CDT
--Earnings per diluted share of $1.09
ROG: 68.95 (+0.58)
Rogers Corporation Invites You to Join its Third Quarter 2014 Conference Call
Business Wire - Tue Oct 21, 7:27AM CDT
Rogers Corporation (NYSE: ROG) plans to release results for its 2014 third quarter after the close of trading on Tuesday, October 28, 2014. A copy of the announcement will be available on the Rogers website at www.rogerscorp.com/news.
ROG: 68.95 (+0.58)
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors
GlobeNewswire - Mon Oct 20, 6:00AM CDT
NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, announced today that they have entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group (SIX:RO) (SIX:ROG) (OTCQX:RHHBY), for the development of NLG919, NewLink's IDO pathway inhibitor. The parties also entered into a research collaboration for the discovery of next generation IDO/TDO compounds.
NLNK: 32.61 (-0.04), ROG: 68.95 (+0.58)
Rogers names Helene Simonet to its board as director
M2 - Wed Oct 15, 6:57AM CDT
Rogers Corporation (NYSE:ROG), a high-performance engineered materials solutions company, announced on Wednesday that Helene Simonet has been appointed to its board of directors, filling the vacancy left by a recently retired director.
ROG: 68.95 (+0.58), COHR: 64.84 (-0.31)
Shares of ROG Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 14, 5:06PM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 16.14% as of today's recent price of $53.40.
ROG: 68.95 (+0.58)
Rogers Corporation Appoints Helene Simonet to Its Board of Directors
Business Wire - Tue Oct 14, 3:00PM CDT
Rogers Corporation (NYSE: ROG) today announced that its Board of Directors has appointed Helene Simonet to serve as a member of the Company's Board. This addition fills a vacancy on the Board due to a recent director retirement. Ms. Simonet will be a member of the Audit Committee.
ROG: 68.95 (+0.58), COHR: 64.84 (-0.31)
Rogers Shares Down 15.4% Since SmarTrend's Sell Call (ROG)
Comtex SmarTrend(R) - Tue Oct 07, 11:08AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 15.37% as of today's recent price of $53.89.
ROG: 68.95 (+0.58)
Industry Leaders Form the RF Energy Alliance to Facilitate the Adoption of Solid-State RF Energy Technology
Business Wire - Mon Oct 06, 9:00AM CDT
Industry leaders, including E.G.O. Elektro-Geratebau GmbH, Huber+Suhner, ITW, NXP Semiconductors, Rogers Corporation and Whirlpool R&D (an affiliate company of Whirlpool Corporation), today announced the formation of the RF Energy Alliance. This consortium intends to advance today's power and heating solutions by equipping engineers and designers with a transformative, cost-effective and highly efficient heating and power source--solid-state radio frequency (RF) energy. To achieve this, the Alliance will drive the development of standards, education and promotion of solid-state RF energy.
WHR: 172.60 (+0.55), ROG: 68.95 (+0.58)
14.4% Return Seen to Date on SmarTrend Rogers Call (ROG)
Comtex SmarTrend(R) - Tue Sep 30, 9:44AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 2 months, Rogers has returned 14.43% as of today's recent price of $54.49.
ROG: 68.95 (+0.58)
Analysis of the Global High-performance (HP) Foams Market Outlook 2018 Featuring 3M, Rogers Corporation, Saint Gobain & Zotefoam
M2 - Thu Sep 25, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpv22d/analysis_of_the) has announced the addition of the "Analysis of the Global High-performance (HP) Foams Market" report to their offering. This research service identifies the major industry drivers, restraints, regional trends, and segment trends in the global HP foams market. The research covers 4 regions: North America, Europe, Asia-Pacific, and Rest of World and accounts for revenue generated from urethane, silicone, and polyvinylidene fluoride (PVDF) foams used in construction and transportation (automotive, rail, and aerospace) applications. Competitive structure and dynamics have been provided at the segment level. Unit shipment, revenue forecasts, and pricing trends are also provided for each segment. The base year is 2013, and the forecast period is from 2014 to 2018. Key Questions This Study Will Answer - Is the market growing, how long will it continue to grow, and at what rate? - What are some of the factors that have had a significant impact on the market's performance? - Who are the market leaders? How might the structure of the market change over time? - How are the existing competitors structuring themselves correctly to meet customer needs? - Are today's products meeting end-user needs? How are manufacturers marketing new products? - Which product attributes do end users find most important? How do these impact selection? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Drivers And Restraints - Total Hp Foams Market 4. Forecast And Trends - Total Hp Foams Market 5. Market Share And Competitive Analysis - Total Hp Foams Market 6. Ceo'S 360 Degree Perspectiveon The Total Hp Foams Market 7. Urethane Segment Breakdown 8. Silicone Segment Breakdown 9. PVDF Segment Breakdown 10. The Last Word 11. Appendix Companies Mentioned - 3M - Rogers Corporation - Saint Gobain - Zotefoam For more information visit http://www.researchandmarkets.com/research/zp...sis_of_the
ROG: 68.95 (+0.58)
Rogers Has Returned 11.7% Since SmarTrend Recommendation (ROG)
Comtex SmarTrend(R) - Tue Sep 23, 9:18AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 2 months, Rogers has returned 11.75% as of today's recent price of $56.20.
ROG: 68.95 (+0.58)
Seragon Pharmaceuticals Inc. Announces Closing of Its Acquisition by Genentech
GlobeNewswire - Wed Aug 27, 3:15PM CDT
Seragon Pharmaceuticals Inc., a leader in developing drugs for hormone dependent cancers, today announced the closing of its acquisition by Genentech, a member of the Roche Group, (SIX:RO) (SIX:ROG) (OTCQX:RHHBY). Deal terms included $725 million in cash up front along with $1.0 billion in contingent development milestone payments for total transaction value up to $1.725 billion. The acquisition includes Seragon's entire selective estrogen receptor degrader (SERD) program, including its most advanced compound, ARN-810, a next generation SERD that is currently being evaluated in a Phase I trial in postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) breast cancer.
ROG: 68.95 (+0.58)
Harwood Feffer LLP Announces Investigation of Intermune, Inc.
PR Newswire - Mon Aug 25, 1:17PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Intermune, Inc. ("Intermune" or the "Company"
(NASDAQ: ITMN) concerning the proposed acquisition of the Company by Roche Holding AG ("Roche" (SIX:ROG) (OTCQX:RHHBY). ITMN: 73.89 (-0.02), ROG: 68.95 (+0.58)
What Falling Estimates & Price Mean for Rogers Corporation (ROG) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 7:43AM CDT
Rogers Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
NJ: 16.82 (+0.15), PKE: 25.40 (-0.40), ROG: 68.95 (+0.58), AVX: 14.33 (-0.11)
Rogers Corporation Reports All-Time Record Quarterly Sales for the Second Quarter of 2014
Business Wire - Tue Jul 29, 3:02PM CDT
--37.2% gross margin -- up 330 basis points relative to prior year non-GAAP measure
ROG: 68.95 (+0.58)
(0)
(0)Rogers Corp. (ROG) Stock Research Links
Scroll down for more posts ▼